Celliaz Co., Ltd.
PrivateLast Round
Seed
Sep 1, 2022
Company Overview
Celliaz Co., Ltd. is a biotechnology company that develops homeoprotein-based retinal regeneration therapies for degenerative retinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celliaz Co., Ltd. Comparables
Compare Celliaz Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Olive Bio Therapeutics | 86% | |
| Ray Therapeutics | 77% | |
| Atsena Therapeutics | 77% | |
Celliaz Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 1, 2022 |
Celliaz Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Genaxis | Seed |
| FuturePlay | Seed |
| IBK Changgong | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2022
Seed round raised with participation from Genaxis, FuturePlay, IBK Changgong, and Seoul Biohub.
Celliaz Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Celliaz Co., Ltd.'s valuation, stock price, and market status.